Amaphrojekthi e-doxycycline hydrochloride, i-amoxicillin kanye ne-ivermectin e-Hebei Xinghua Biotechnology Co., Ltd. amboza indawo yonke engamamitha-skwele angu-40326.56 kanye nendawo yonke yokwakha engamamitha-skwele angu-29658.89. Imali etshaliwe yalo msebenzi ingu-369 million yuan, kanti isikhathi sokwakha siyizinsuku ezingu-200. Kusukela ngoMashi kuya kuJuni 2023, isakhiwo esiyinhloko sesakhiwo, imigwaqo yangaphakathi yendawo yefektri, kanye nezindawo ezisizayo ezifana namanzi, ugesi, ukushisa kanye nokungenisa umoya kuzoqedwa. Ngo-Okthoba 2023, ukuhlelwa kwenqubo ye-workshop, ukufakwa kwemishini yokukhiqiza, inethiwekhi yamapayipi okuhlanza imithi, ukuhlobisa kwangaphakathi, kanye namaphrojekthi okuhlola ikhwalithi yokuhlola konke kuzoqedwa. Ekupheleni kuka-2023, inguqulo entsha kazwelonke yokwamukelwa kwemithi yezilwane ye-GMP kanye nokuvunyelwa komkhiqizo kanye nokumenyezelwa kwenombolo yebhetshi kuzoqedwa. Izoqaliswa ngokusemthethweni ukusebenza ngo-2024. Lo msebenzi uwumsebenzi obalulekile eShijiazhuang.

Ngemva kweminyaka engama-20 yentuthuko yebhizinisi, inkampani yethu ithole indawo embonini. I-Xinghua Biology, eyaqala ukwakhiwa ngoMashi 2, 2023, isivumele ukuthi sithathe imboni siye ezingeni eliphakeme. Ngezinto zokusetshenziswa, singakha ikusasa elingcono lentuthuko yethu yesikhathi esizayo. Ipulatifomu enkulu, i-Hebei Xinghua Biotechnology Co., Ltd. iphrojekthi ye-doxycycline hydrochloride, i-amoxicillin, i-ivermectin, umcimbi wokubeka itshe lesisekelo uphethwe ngempumelelo!

Ngokusekelwe endaweni entsha yokuqala, qala uhambo olusha bese udala ubuhlakani obusha.